Photo taken on June 1, 2021 shows vials of Sinopharm vaccines in Beijing, capital of China. (Xinhua)

BEIJING, July 13  -- Two Chinese pharmaceutical companies will provide 110 million doses of COVID-19 vaccines immediately to participants of the COVAX project, announced the global Vaccine Alliance Gavi on Monday.

The Chinese Sinopharm and Sinovac vaccines have been approved earlier this year by the World Health Organization (WHO) for emergency use.

China is the world's largest vaccine supplier, having supplied more than 480 million doses of COVID-19 vaccines to the international community, provided vaccine assistance to nearly 100 countries, and exported vaccines to more than 50 countries.

With Chinese vaccines being administered worldwide, they have been found, according to multiple studies, highly effective in preventing infection, hospitalization, severe illness and death from the virus.